Single-cell RNA-sequencing in novel preventative and therapeutic applications in breast cancer-related lymphedema
Year: 2024
Type: dissertation
Abstract: Single-cell RNA-sequencing (scRNA-seq) is a form of new generation sequencing (NGS). It can be used to gather and analyse large datasets of single cells involving ribonucleic acid (RNA) -activity with precision and efficiency unattained by previous methods. scRNA-seq can be used to ascertain rare and detailed changes in a cell’s transcriptomic and proteomic activity in varying environments. In a clinical setting, it can be used to identify or guide new potential targeted therapies. Axillary lymph node dissection and biopsy, as well as radiative treatments and chemotherapy in conjunction with breast cancer surgery damage the axillary lymphatic system and heighten the risk of breast cancer-related lymphedema (BCRL) in the upper extremity. No curative or preventative treatment exists to date. Utilization of scRNA-seq could lead to new solutions regarding pharmacotherapeutic development in chronic secondary lymphedema. The aim of this literature review was to compile previous cellular and molecular information regarding lymphedema and present results gained about secondary lymphedema pathophysiology using scRNA-seq methods. scRNA-seq results suggest a pivotal role of CD4+-cells and TREM1-receptor overexpression in chronic inflammation, adipose hypertrophy, and fibrosis. A heightened expression of the LPL-gene and PPAR-gamma lead to adipose hypertrophy and the CLEC3B-gene in fibrotic progression. Dysregulated VEGF and PGFD signaling was central in inflammation, adipose hypertrophy, and fibrosis. Future studies would benefit from determining, whether molecular or cellular changes occur prior to discernible lymphedema. Surgical and conservative treatments have steadily secured a role in secondary lymphedema treatment, but scRNA-seq holds vast potential in developing novel targeted pharmacotherapeutic solutions for BCRL.
Source: UTUPub (University of Turku)
Author: Suomi, Rebecca
Institution: University of Turku
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W6987147984
